MD Medical Group named ‘IPO of the Year’ at Russian CFO Awards
MD Medical Group Investments Plc, Russia’s leading provider of private women’s and children’s health care, is pleased to announce that it received the Best capital-raising Strategy award at the Adam Smith Russian CFO Awards 2013, following the company’s successful IPO in October 2012.
Vitali Ustimenko, CFO of MD Medical Group, who received the award at a ceremony held last night in Moscow, said:
“On behalf of the entire MDMG team, I am delighted that our IPO has been recognised with such a prestigious award. We went to the market at what was a challenging time for global financial markets, but our story was strong and the execution of the deal was flawless. This is what enabled us to attract such robust and diverse investor demand and to price the deal attractively, while at the same time leaving value on the table for investors that supported us during and following the transaction.”
* * *
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.
2020 2019 2018 2017 2016 2015 2014 2013 2012